Chau Q. Khuong is General Partner & Senior Advisor at Catalio Capital Management, LP., where he serves on the Nexus, Credit Opportunities and Public Equities Investment Committees.
Prior to joining Catalio, Chau was at OrbiMed Advisors, a global multi strategy investment firm focused exclusively in healthcare. Chau joined OrbiMed in 2003, where he contributed significantly to the firm’s growth into one of the premier healthcare-focused investing organizations globally. At the time of his retirement from OrbiMed in December 2021, Chau was Partner and Member of the Investment Committee for the OrbiMed venture capital funds. He has led or co-led investments into over two dozen life science companies, resulting ultimately in twelve FDA approved medicines or therapeutic devices. Chau has served on the Board of Directors of numerous public and private biotech companies.
Chau earned a B.S. and an M.P.H. both from Yale University.